rspНаучно-практическая ревматологияRheumatology Science and Practice1995-44841995-4492IMA-PRESS, LLC10.14412/1995-4484-2010-736rsp-873Research ArticleСтатьиArticlesЭФФЕКТИВНОСТЬ РИТУКСИМАБА ПРИ СИНДРОМЕ СТИЛЛА У ВЗРОСЛОГО ПАЦИЕНТА (ОПИСАНИЕ СЛУЧАЯ)EFFEKTIVNOST' RITUKSIMABA PRI SINDROME STILLA U VZROSLOGO PATsIENTA (OPISANIE SLUChAYa)ТарасоваГ. М.TarasovaGalina Mikhailovnaverizub@gmail.com <mailto:verizub@gmail.com>БалабановаРимма МихайловнаBalabanovaR M-СажинаЕ. Г.SazhinaE G-ОлюнинЮрий АлексанровичOlyuninYu A-НасоновЕвгений ЛьвовичNasonovE L-201015102010485№5 (2010)8588Copyright © Тарасова Г.М., Балабанова Р.М., Сажина Е.Г., Олюнин Ю.А., Насонов Е.Л., 20102010Тарасова Г.М., Балабанова Р.М., Сажина Е.Г., Олюнин Ю.А., Насонов Е.Л.Tarasova G.M., Balabanova R.M., Sazhina E.G., Olyunin Y.A., Nasonov E.L.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://rsp.mediar-press.net/rsp/article/view/873References<div><p>Yamaguchi M., Ohta A., Tsunematsu T. et al. Preliminary criteria for classification of adult onset Still's disease. J Rheumatol 1992; 19: 424-30.</p><p>Hamidou M.A., Denis M., Barbarot S. et al. Usefulness of glycosylated ferritin in atypical presentations of adult onset Still's disease. Ann Rheum Dis 2004; 63: 605.</p><p>Sono H., Matsuo K., Miyazato H. et al. A case of adult onset Still's disease complicated by non-Hodgkin's lymphoma. Lupus 2000; 9: 468-70.</p><p>Fautrel B., Sibilia J., Mariette X. et al. Tumor necrosis factor a blocking agents in refractery adult Still's disease; an observation study of 20 cases. Ann Rheum Dis 2005; 64(2): 262-6.</p><p>Lequerre T., Quartier P., Rosselini D. et al. IL-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still's disease. Ann Rheum Dis 2008; 67(3): 302-8.</p><p>De Bandt M., Saint-Marcos B. Tocilizumab for multirefractory adult onset Still's disease. Ann Rheum Dis 2009; 68: 153-4.</p><p>Ahmadi-Simab K., Lamprecht P., Jankowiak C. et al. Successful treatment of refractory adult onset Still's disease with retuхimab. Ann Rheum Dis 2006; 65: 1117-8.</p><p>Nissen M.I., Fontanges E., Allam Y. et al. Rheumatological manifestations of hepatitis C: incidence in a rheumatology and non-rheumatology setting and the effect of methotreхate and interferon. Reumatology (Oxford) 2005; 44(8): 1016-20.</p><p>Chuang E., Del Vecchio A., Smolinski S. et al. Biomedicins to reduce inflamation but not viral load in chronic HCV-what's the cause? Trends Biotechnol 2004; 22(10): 517- 23.</p><p>Antonelli A., Ferry C., Galeazzi M. et al. HCV-infection: pathogenesis, clinical manifestation and therapy. Clin Exp Rheum 2008; 26(1): 39-47.</p><p>Efthimiou P., Georgy S. Pathogenesis and management of AOSD. Semin Arthr Rheum 2006; 36: 144-52.</p><p>Bartoloni E., Alunno A., Luccioli F. et al. Successful treatment of refractory adult- onset Still's disease with anti-CD20 monoclonal antibody. Clin Exper Rheum 2009; 27(5): 888-9.</p></div><br /><div><p>Yamaguchi M., Ohta A., Tsunematsu T. et al. Preliminary criteria for classification of adult onset Still's disease. J Rheumatol 1992; 19: 424-30.</p><p>Hamidou M.A., Denis M., Barbarot S. et al. Usefulness of glycosylated ferritin in atypical presentations of adult onset Still's disease. Ann Rheum Dis 2004; 63: 605.</p><p>Sono H., Matsuo K., Miyazato H. et al. A case of adult onset Still's disease complicated by non-Hodgkin's lymphoma. Lupus 2000; 9: 468-70.</p><p>Fautrel B., Sibilia J., Mariette X. et al. Tumor necrosis factor a blocking agents in refractery adult Still's disease; an observation study of 20 cases. Ann Rheum Dis 2005; 64(2): 262-6.</p><p>Lequerre T., Quartier P., Rosselini D. et al. IL-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still's disease. Ann Rheum Dis 2008; 67(3): 302-8.</p><p>De Bandt M., Saint-Marcos B. Tocilizumab for multirefractory adult onset Still's disease. Ann Rheum Dis 2009; 68: 153-4.</p><p>Ahmadi-Simab K., Lamprecht P., Jankowiak C. et al. Successful treatment of refractory adult onset Still's disease with retuхimab. Ann Rheum Dis 2006; 65: 1117-8.</p><p>Nissen M.I., Fontanges E., Allam Y. et al. Rheumatological manifestations of hepatitis C: incidence in a rheumatology and non-rheumatology setting and the effect of methotreхate and interferon. Reumatology (Oxford) 2005; 44(8): 1016-20.</p><p>Chuang E., Del Vecchio A., Smolinski S. et al. Biomedicins to reduce inflamation but not viral load in chronic HCV-what's the cause? Trends Biotechnol 2004; 22(10): 517- 23.</p><p>Antonelli A., Ferry C., Galeazzi M. et al. HCV-infection: pathogenesis, clinical manifestation and therapy. Clin Exp Rheum 2008; 26(1): 39-47.</p><p>Efthimiou P., Georgy S. Pathogenesis and management of AOSD. Semin Arthr Rheum 2006; 36: 144-52.</p><p>Bartoloni E., Alunno A., Luccioli F. et al. Successful treatment of refractory adult- onset Still's disease with anti-CD20 monoclonal antibody. Clin Exper Rheum 2009; 27(5): 888-9.</p></div><br />
The authors declare that there are no conflicts of interest present.